SUMMARY
INTRODUCTION
Neurons grow two characteristic processes: axons and dendrites. The specification of these processes, their outgrowth, and their precise arborization are prerequisites for the formation of appropriate connections between neurons. These steps, which constitute the basis for the establishment of neuronal circuits, represent central questions in neuroscience for which the molecular mechanisms still remain largely unsolved.
The dendrite formation, which is critical for proper integration of synaptic inputs, is believed to be determined by genetically encoded cell-intrinsic signals as well as environmental-extrinsic signals from neighboring cells. Recent works have shed light on the critical roles of semaphorin 3A, neurotrophins, Notch1, Slit-1, cadherin, BMP, and Wnt/b-catenin in mediating signaling events regulating various stages of dendritogenesis in the developing cerebral cortex (reviewed in Ciani and Salinas, 2005; Higgins et al., 1997; Jan and Jan, 2003; Whitford et al., 2002) . In addition, a wealth of work has shown that the formation of dendritic trees is shaped by neuronal activity (Cline, 2001; Konur and Ghosh, 2005) . For example, surgical and pharmacological attenuation of sensory inputs impaired dendritic development in the visual cortex as well as in the barrel cortex (Fox and Wong, 2005) , while in contrast, enriched environments promoted dendritic growth (Kozorovitskiy et al., 2005) . However, how neural activity regulates dendrite arborization at the molecular and cellular level is not well understood.
Activity-dependent regulation of dendritic arbors is believed to be mediated, in large part, via increases in intracellular calcium concentration, which in turn activate several signaling cascades. How can neuronal activity influence dendrite formation downstream of calcium entry and mobilization? Several works have so far indicated a possible involvement of one or multiple members of the multifunctional Ca 2+ /calmodulin (CaM)-dependent protein kinases (CaMKs) family in dendritic development. CaMKs represent major targets for an activated Ca 2+ / CaM complex generated by intracellular calcium rise, and two subclasses (the CaMKI/IV subfamily [consisting of five genes] and a CaMKII subfamily [consisting of four genes]) have been shown to be highly expressed in the central nervous system (CNS) (Soderling and Stull, 2001; Hook and Means, 2001; Hudmon and Schulman, 2002) . The general CaMK inhibitor KN-62, which inhibited activation of members of both kinase subclasses, was shown to block neurite outgrowth in various cell lines (Zheng et al., 1994; Kuhn et al., 1998; Vaillant et al., 2002) . The role of CaMKII in neurite outgrowth has been controversial, however, in part because of the contrasting effect observed between the a and b isoforms of CaMKII (Konur and Ghosh, 2005) . CaMKIV, enriched in the nucleus, was shown to mediate dendrite formation via CREB phosphorylation and CREB-mediated transcription (Redmond et al., 2002) . Additionally, CaMKI activity may participate in the regulation of growth cone motility and neurite extension Schmitt et al., 2004) , but the underlying isoforms and critical mechanisms involved remained obscure.
Recently, a variety of Rho small GTPase family proteins were shown to contribute to dendritic morphogenesis through regulation of actin cytoskeletal remodeling (Luo, 2002; Van Aelst and Cline, 2004) . How the small GTPase activity was turned on and off as a function of neuronal activity and multiple coexisting extracellular cues remained largely unknown. In some instances, the GDP-GTP exchange factor (GEF) for a Rho small GTPase family protein was shown to be activated downstream of Ca 2+ .
Thus, a synaptically localized Rac-GEF Tiam1 was involved in the regulation of dendritic spines by linking NMDA-receptor activity to Rac1-dependent actin remodeling (Tolias et al., 2005) . However, it was not known whether nor which specific CaMK activity may contribute to small GTPase-dependent dendritic actin remodeling during dendritogenesis. Here, we show a unique function of a lipid-raftassociated Ca 2+ /calmodulin-dependent protein kinase, CLICK-III (CL3)/CaMKIg, in dendritogenesis of developing cortical neurons. The C-terminal end of CL3 was the substrate for sequential lipidifications, i.e., prenylation and palmitoylation. Prenyl-palmitoyl-CL3, generated in a kinase-activity-dependent manner, efficiently accumulated into dendrite-enriched raft-like lipid microdomains. Intriguingly, knockdown or knockout of CL3 reduced the number and the total length of dendrites, but not those of axons. Furthermore, blockade of CL3 occluded BDNF-stimulated dendritic growth, and CL3 membrane anchoring appeared to play an important role in mediating this morphological effect. In keeping with the critical significance of raft insertion of CL3, Rac and its upstream regulator STEF, a Rac-specific GEF, acted downstream of CL3 in the molecular cascade linking Ca 2+ to actin remodeling, and both were present in the lipid rafts. Consistent with these results, Rac activity was sufficient to rescue the dendritic phenotype associated with CL3 knockdown, while raft disruption abolished the dendritogenic effect of CL3 overexpression. Taken together, we thus uncovered a novel CaMK-Rac signaling pathway by which lipid raft insertion and activation of a specific CaMKI isoform may couple extrinsic neuronal activity with dendrite-restricted cytoskeletal remodeling in developing cortical neurons. Figures 1B and 1C , WT). The former was absent in a C474S mutant ( Figure 1B , C474S), consistent with a CAAX prenylation. In contrast, the latter was reduced to background levels in a quadruple mutation (4CS) of four cysteines (C417S, C419S, C420S, and C423S) ( Figure 1C, 4CS ), identifying these residues as potential palmitoylation sites.
RESULTS

Prenylated
We next tested whether there was a possible interaction between prenylation, palmitoylation, and kinase activity. Interestingly, the 4CS mutant was prenylated to a similar extent as the WT CL3 ( Figure 1D ), while palmitoylation was hardly detected in a prenylation-deficient C474S mutant ( Figure 1E ). Thus, prenylation and palmitoylation might take place in a series, with prenylation perhaps occurring prior to and as a prerequisite for palmitoylation. Furthermore, a K52A kinase-inactive mutant of CL3, in which the consensus ATP-binding lysine residue was replaced with an alanine, was prenylated as much as the WT ( Figure 1D ), but its palmitoylation was significantly impaired ( Figure 1E ). These lines of evidence suggested that kinase activation on a prenylated (and thus presumably membrane inserted) CL3 may perhaps trigger a robust conformational change near the membranes that is necessary for full palmitoylation.
Recently, 23 palmitoyl acyl transferases (PATs) have been identified (Fukata et al., 2004; Linder and Deschenes, 2004) . The brain-specific localization and the Golgi enrichment of a PAT, originally identified as a Golgi-apparatus-specific protein with the DHHC zinc finger domain (GODZ) (Uemura et al., 2002) , were reminiscent of the distribution of CL3. We therefore tested whether GODZ might palmitoylate CL3. GODZ coexpression with CL3 in heterologous cells yielded a 4.3-fold increase (4.3 ± 0.55, n = 5) in the amount of palmitate incorporation ( Figure 1F ).
We previously found that prenylation per se may be necessary for membrane anchoring and for trafficking to diverse membrane compartments, such as the Golgi apparatus or the plasma membranes . To test whether an additional palmitoylation may help to redistribute CL3 into specific membrane signalosomes such as those enriched at lipid rafts (Anderson and Jacobson, 2002), we expressed GFP-tagged CL3 (GFP-CL3) in cultured cortical neurons using a lentiviral vector driven by a synapsin I promoter. Consistent with our hypothesis, CL3 cofractionated with the lipid raft markers, caveolin-2 and flotillin-1, in the Triton X-100-insoluble low-density membrane fractions ( Figure 2A ). We next directly visualized raft-inserted CL3 localization in cultured neurons treated with 0.1% Triton X-100, as any residual GFP signal should then be indicative of the presence of CL3 in detergent-resistant membrane microdomains. In keeping with this, a sizable detergent nonextractable pool of GFP-CL3 was present in the perinuclear Golgi and proximal dendrites in developing hippocampal neurons (see Figure S1A in the Supplemental Data available with this article online, -GODZ arrow and arrowhead; and Figure S1B ), and this pool was further increased by coexpression of GODZ ( Figure S1A , +GODZ arrow and arrowheads). In immature cortical neurons, a large majority of the CL3 signal that was resistant to detergent treatment was present both in the intracellular perinuclear Golgi-like membranes and in the minor processes (i.e., dendrites) ( Figure 2B , upper panel, see line scan in the inset for CL3 signal in the dendrites). Importantly, this detergent-resistant pool of CL3 was almost completely lost when neurons were treated with zaragozic acid, an In addition to a classical prenylation site at the Cys-474 residue (in blue) of the C-terminal CAAX motif (double underline), the unique C-terminal region of CL3 contained multiple Cys residues (in red and green), which constituted potential palmitoylation sites. Among them, four neighboring Cys (in red and underlined) were experimentally validated as critical residues for palmitoylation, as shown also in (C (D) Unchanged level of prenylation on both a palmitoylation-deficient (4CS) and a kinase-dead (K52A, a Lys residue in the ATP-binding pocket replaced with an Ala) mutant of CL3.
(E) A decrease in palmitoylation was observed in a prenylation-deficient mutant (C474S), as well as a kinase-inactive mutant (K52A).
(F) Coexpression of HA-GODZ, a neuronal palmitoyl acyl transferase, led to a significant increase in CL3 palmitoylation by 4.32 ± 0.55 fold (n = 5). **p < 0.01 by paired t test.
inhibitor of squalene synthase that efficiently depletes membrane cholesterol ( Figure 2B , lower panel). These results indicated that CL3 was a genuine component of dendritic lipid rafts and that raft insertion was likely regulated by CL3 prenylation and palmitoylation. Does CL3 actually share some of the properties known for dendritic raft signaling molecules? A number of raft proteins were previously reported to homo-oligomerize into a multimeric protein complex via lipidification (Zacharias et al., 2002; Huang and El-Husseini, 2005) . Indeed, HA-tagged WT CL3 coimmunoprecipitated with GFP-CL3 ( Figure 2C ) in cortical neurons. Furthermore, a significant fluorescence energy transfer (FRET) was detected between coexpressed CFP-CL3 and YFP-CL3 in live hippocampal neurons, indicative of their genuine molecular proximity in a complex ( Figure S2A ). Interestingly, Lyn, a well known raft-enriched molecule, colocalized with CL3 in live-untreated, but not in detergent-treated, neurons ( Figure S2B ). In contrast, the distribution of GluR1, a dendritic protein that is targeted to lipid rafts by palmitoylation (Suzuki et al., 2001; Hering et al. 2003; Hayashi et al. 2005) , partially overlapped with CL3 even in detergenttreated neurons ( Figure S2C ).
CL3 Promotes Dendritogenesis in Cortical Neurons
From previous studies Wayman et al., 2004) , it has been speculated that the CaMKK-CaMKI pathway might play a role in the control of neuronal morphology during development. In situ hybridization of embryonic day 17.5 (E17.5) tissues revealed a strong expression of CL3 transcript in the forebrain ( Figures 3A and 3B ) and in particular in the cortical plate of the cerebral cortex ( Figures 3C and 3D ). To test whether CL3 was involved in neuronal morphogenesis during this period, either GFP or GFP-CL3 cDNAs were (A) Wild-type GFP-CL3 (WT) expressed in cortical neurons using a synapsin I promoterdriven lentivirus was recovered in the lipid raft fraction (lanes 4-5), as confirmed by the enrichment of raft marker proteins flotillin-1 and caveolin-2 (Cav-2). Fractions 1-4, 5% sucrose; 5-12, 35% sucrose; 13, 50% sucrose. (B) A sizable portion of total GFP-CL3 fluorescence was recovered after detergent treatment as detergent-resistant GFP-CL3, which was localized in a punctate manner in 2 DIV cortical neurons along the dendrites as well as at the perinuclear region. Dendrites were unambiguously identified as processes of limited length (much shorter than the axon exceeding 100 mm). Line scans of pixel fluorescence, carried out within a chosen field of a 15 mm dendritic segment (in insets 1 and 2) by horizontally tracking the clusters of GFP-CL3, illustrate the spotty presence of raftinserted CL3 along the dendrites (right panels). Treatment with 100 mM zaragozic acid abolished the dendritic detergent-resistant patches and flattened the line scan profile. Scale bar, 10 mm. (C) CL3 forms a multimeric complex in cortical neurons. Wild-type CL3 tagged with either HAtag (HA-CL3) or GFP (GFP-CL3) were coexpressed in cortical neurons by nucleofection and coimmunoprecipitated using an anti-GFP antibody. In, input; IP, immunoprecipitates. electroporated into cortical neurons immediately upon dissociation, and the morphology of the neurons was examined 48 hr later, a time point when the majority of neurons under our culture conditions developed welldiscernable dendrites and one axon. In control GFPexpressing neurons, little GFP fluorescence overlapped with a Golgi membrane marker, GM130 (Figures 3E and 3F, arrow) . In GFP-CL3-overexpressing cortical neurons, however, GFP fluorescence colocalized with GM130 (Figures 3G and 3H, arrow) and also showed discrete enrichment within several dendritic processes (Figures 3G and 3H, arrowhead) . Compared to GFP-expressing control neurons ( Figure 3I ), GFP-CL3-overexpressing neurons appeared to exhibit unaltered axonal extension and branching, while in contrast, increased dendritic growth was found at and in the very vicinity of the soma ( Figure 3L ). In keeping with this finding, coexpression of mCherry-actin with GFP-CL3 ( Figures 3M and 3N ), but not with GFP ( Figures 3J and 3K ), revealed an augmentation of actin-enriched tips at the growing ends ( Figures 3M  and 3N , arrows) of the nascent processes extending out from the soma, consistent with activation of an actin cytoskeletal remodeling process. To quantify the morphological changes associated with CL3 overexpression, morphometric analyses were performed on the dendrites of GFP-CL3-expressing cortical neurons in a blind fashion. We found that total dendritic length, and in particular the length of the longest dendrite, was most strikingly increased by CL3 overexpression, while the change in branch-tip number remained small and not significant ( Figure 3O ). CL3-dependent promotion of dendritic growth was detected equally over the whole range of length of primary dendrites ( Figure 3P ), suggesting that the CL3 effect was unlikely to be restricted to just a subgroup of dendrites, but rather promoted a key common step in early dendritic formation. This CL3-induced effect was not seen with a kinase-inactive K52A mutant (data not shown). Together, these sets of evidence suggested the possibility that CL3 may be involved in early stages of dendritogenesis in developing cortical neurons.
A Required Role of CL3 in Dendritogenesis but Not in Axonogenesis
To critically test this possibility, we next examined the neuronal morphology in neurons where CL3 expression was strongly attenuated by RNA interference, using a short hairpin-type pSUPER vector that also coexpressed a PGK promoter-driven EGFP or mRFP1 gene cassette for morphological tracing. The knockdown efficiency and specificity of the shCL3 vector was prominent enough such that even an overexpressed GFP-CL3 became barely detectable 48 hr after transfection, while the control mRFP1 expression level remained unchanged ( Figure 4A ). This shCL3 vector was introduced into embryonic cortical neurons by electroporation, and formation of dendrites and axons was studied 48 hr later. While the cortical neurons showed 5-6 dendritic processes in control experiments, shCL3-treated neurons revealed a notable impairment in the number and total length of MAP2-positive dendrites ( Figure 4B , arrows). In striking contrast, formation of Tau-1-positive axons was largely spared ( Figure 4B , arrowheads). Quantitative morphometric analyses on dendritic or axonal arborizations confirmed that the impairment in shCL3-transfected neurons was actually confined to a selective decline in total dendritic length and in total tip number and did not affect either axonal outgrowth or branching ( Figures 4C and 4D ). The reduction in dendritic growth was observed throughout the whole range of dendrite length ( Figure S3 ). The striking specificity in dendritic phenotype was also sustained even in shCL3-transfected neurons that were plated following an extensive period (48 hr) of suspension culture that allowed them to maximize the effect of knockdown prior to plating ( Figure S4 ). Knockdown of either CaMKIIa or CaMKIV revealed no phenotype, at least during the very early dendritogenic period that we examined ( Figure S5 ). Taken together, knockdown of CL3 did not interfere with the process of axon specification or axonogenesis, but rather suppressed a subsequent process that was required for dendritogenesis. We next asked whether CL3's kinase activation was a genuine requirement. The abnormality in dendritogenesis could be rescued by additional expression of an shCL3-resistant WT (kinase-active) CL3, but not by that of an shCL3-resistant K52A (kinaseinactive) CL3, demonstrating the absolute necessity of CL3 kinase activity during dendritogenesis ( Figure 4E ). Consistently, early dendritogenesis, but not axonogenesis, was also impaired in cultured cortical neurons obtained from CL3 null mice ( Figure 4F ).
In 9 DIV hippocampal neurons, CL3 knockdown diminished total dendritic length and primary dendrite number ( Figure S6 ) and induced an altered Golgi morphology ( Figure S7 ), which was somewhat reminiscent of Golgi vesiculation associated with impaired dendritic polarity (Horton et al., 2005) .
A Required Role for CL3 in BDNF-Stimulated Dendritic Growth
We then asked what calcium mobilization might contribute to CL3-dependent stimulation of dendrite development. Brain-derived neurotrophic factor (BDNF) was previously shown to strongly promote dendrite growth and trigger an intracellular calcium rise (e.g., Huang and Reichardt, 2003 , for a review). Consistent with published literature, bath application of BDNF induced a slow but clear increase in intracellular Ca 2+ concentration in the cultured cortical neurons used in our study ( Figures 5A-5C ). Latencies of onset and oscillatory amplitudes/ frequencies varied from neuron to neuron (Figures 5B and 5C) . Continuous treatment of cortical neurons with BDNF significantly promoted dendritic growth ( Figure 5D , p < 0.05, ANOVA with post hoc Tukey-Kramer test). In the presence of a global blocker of CaM kinase activation, KN-93, both constitutive and BDNF-stimulated components of dendritic growth were strongly inhibited ( Figure 5D ). Because KN-93 suppressed dendritic growth to a similar extent under either constitutive or BDNFstimulated conditions, this raised the possibility of a common involvement of a KN-93-sensitive kinase (Figure 5D ). To specifically test this idea, we employed RNAi and measured the degree of suppression of dendritic growth in the absence or presence of BDNF application and found that indeed CL3 knockdown completely phenocopied the effect of KN-93 on dendrites and occluded BDNF-stimulated dendritic growth ( Figure 5E ).
(O) Facilitation of dendritic outgrowth by CL3 overexpression. Total length, branch tip number, and longest dendrite length are shown. Number of neurons: GFP, n = 30; GFP-CL3, n = 30. ***p < 0.001; n.s., not significant (p > 0.05) (t test).
(P) Cumulative probability analysis shows a significant extension of primary dendrites in GFP-CL3-expressing neurons (**p < 0.01, KolmogorovSmirnov test). Numbers of examined dendrites: GFP, n = 258 (from 50 neurons); GFP-CL3, n = 321 (from 50 neurons). Scale bars, 300 mm (A and B); 50 mm (C and D); 10 mm (E-H); 20 mm (I-N).
Figure 4. CL3 Loss-of-Function in Embryonic Cortical Neurons Elicits a Specific Impairment in Dendrite Morphogenesis
(A) Efficient downregulation of exogenous GFP-CL3 was achieved by a CL3-targeted shRNA vector (pSUPER-shCL3), but not by a control vector (pSUPER-shNega), in embryonic cortical neurons. The mRFP1 expression, which was driven by a dual promoter in a pSUPER + mRFP1 vector cassette, remained unchanged.
(B) A representative confocal image of an shCL3/ GFP-expressing neuron (pSUPER-shCL3) showing impaired dendritogenesis. In this example, an shCL3-expressiong neuron had only a single remaining dendrite (an arrow in the inset), while an shNega-transfected neuron carried 5-6 dendrites (arrows in the inset). On the other hand, no change in axonal morphology was detected (arrowheads). Tau-1 and MAP2 were used to identify axons and dendrites, respectively. (C) Monochrome diagrams of representative shNega-or shCL3-expressing neurons. The longest process (axon) was unchanged, while the morphology of shorter dendrites near the cell soma was much simplified in shCL3-transfected neurons.
(D) Quantification of morphometric parameters in CL3-knockdown neurons. To quantify, the total length and the dendritic branch tip number were calculated over the dendritic or the axonal arborizations for all branches exceeding 7 mm in length. In shCL3-expressing neurons, both parameters were significantly reduced in the dendrites. On the other hand, neither axonal length nor axonal branch tip number were significantly altered. Number of neurons: shNega, n = 78; shCL3, n = 53. ***p < 0.001; n.s., not significant (p > 0.05) (t test). (E) Requirement for CL3 kinase activity to rescue shCL3-mediated impairment in dendritogenesis. Introduction of an shCL3-resistant silent mutant of wild-type GFP-CL3 (WT res ) successfully rescued the dendritic phenotype elicited by shCL3 on both morphometric parameters. The shCL3-resistant kinaseinactive GFP-CL3 (K52A res ) was unable to rescue the shCL3 phenotype. Number of neurons: shNega, n = 37; shCL3 + mock, n = 35; shCL3 + WT res , n = 41; shCL3 + K52A res , n = 33. **p < 0.01; ***p < 0.001; n.s., not significant (p > 0.05) (ANOVA with post hoc Tukey-Kramer test). (F) Dendritogenesis, but not axonogenesis, is specifically impaired in cultured cortical neurons from CL3-KO mice. WT, n = 20; CL3-KO, n = 20. *p < 0.05; **p < 0.01; n.s., not significant (p > 0.05) (t test). Scale bars, 50 mm (A-C) and 20 mm ([B], inset).
Furthermore, dendritic growth was rescued by coexpressing an shCL3-resistant wild-type, but not a membrane anchoring-defective CL3 mutant ( Figure 5F ). Thus, signaling via membrane-anchored CL3 may play a critical role in BDNF-mediated cortical dendritogenesis during early development.
A Lipid-Raft-Delineated CL3-STEF-Rac Pathway Contributes to the Development of Cortical Dendrites What are the signaling components that underlie lipidified CL3-mediated dendritic growth? Taking advantage of our finding that CL3 overexpression was accompanied by a sizable increase in the length of primary dendrites (Figures 3O, 3P , and 6A), and in particular its longest dendrite ( Figure 3O , right panel; Figure 6B ), we next tested the possible contribution of small GTPases downstream of CL3. Coexpression of a dominant-negative Rac abolished the effect of CL3 overexpression ( Figures 6A and 6B ), and this effect was seen throughout the observed range of primary dendrite length ( Figure 6C ), supporting the idea that Rac mediated CL3-stimulated dendritic growth. Consistently, we found that CL3 knockdown downregulated Rac activity ( Figure 6D ). Furthermore, overexpression of a dominant interfering fragment (PHnTSS) of STEF, a specific RacGEF previously implicated in cortical migration and neurite outgrowth (Kawauchi et al., 2003; Matsuo et al., 2002) , also potently repressed the CL3 effect (Figures 6A and 6B) ; however, this effect was less pronounced in dendrites with shorter lengths (<20 mm) ( Figure 6C ). Both STEF and Rac were detected in the Triton X-100-insoluble low-density membrane fractions enriched for flotillin-1 but devoid of transferrin receptors ( Figure 6E ), consistent with the presence of a raft-delineated CL3-STEF-Rac pathway. In keeping with this, sustained Rac activity significantly attenuated the impairment in dendrite development observed in CL3-diminished neurons ( Figures 6F and 6G) .
If raft localization of CL3 was critical for CL3-dependent dendritogenesis, a raft depletion by pharmacological manipulation or a removal of CL3 from rafts by mutation of its palmitoylation sites should significantly perturb dendrite formation and growth. To test this, we pretreated cortical neurons with either mevastatin, an HMG-CoA reductase inhibitor, to deplete membrane cholesterol, and/or with fumonisin B 1 , an inhibitor of sphingolipid synthesis. Treatment with either mevastatin or, to a lesser extent, with fumonisin B 1 reduced dendritogenesis (Figures 7A and 7B) . A combination of both had no further additive effect (Figures 7A and 7B ). As mevastatin was expected to interfere not only with cholesterol synthesis alone but also with protein prenylation, we also examined the effect of zaragozic acid, an inhibitor of squalene synthase, which would disrupt cholesterol synthesis while sparing mevalonate production. Zaragozic acid treatment diminished dendrite formation to a degree similar to the effect seen with mevastatin; a combination of both did not produce a further incremental effect ( Figures 7A and  7B) . Interestingly, raft depletion by treatment with zaragozic acid abolished the dendritogenic action of overexpressed CL3 ( Figure 7C ). Together, these results further supported the idea that the presence of intact lipid rafts was critical for CL3 to exhibit its dendritic effect.
In keeping with this, a palmitoylation-site-deficient 4CS mutant of CL3, which was made resistant to shCL3 RNAi vector, was unable to rescue the dendritic effect of CL3 knockdown in cortical neurons ( Figure S4C ). Intriguingly, in hippocampal neurons, the inaccessibility of 4CS mutant protein toward detergent-resistant raft membranes in CL3-knockdown cells ( Figure S8A ) was accompanied with the appearance of exuberant thin filopodial processes from the soma (Figure S8B, arrows) . These results are consistent with a role of palmitoylation in targeting, and perhaps restricting, CL3 expression to its appropriate sites of cellular actions. Taken together, CL3 palmitoylation may be a useful means to restrict STEF-Rac activation to microdomains in the vicinity of dendritic rafts during early dendritogenesis.
DISCUSSION
Identification of CL3/CaMKIg as a Privileged Kinase Involved in the Regulation of Dendritic Cytoarchitecture during Early CNS Development
Previous analyses have established the necessity of CaMKII, a predominant form of CaM kinase, as molecular switch required for neuroplasticity in the hippocampus, the barrel cortex, and the visual cortex (Lisman et al., 2002; Fox and Wong, 2005) . Furthermore, the role of CaMKII isoforms in several forms of dendritic development was extensively studied, though the exact effect on dendrite morphogenesis has remained rather controversial. CaMKIIa was shown to contribute to dendritic outgrowth in cerebellar granule neurons (Gaudilliere et al., 2004) , and CaMKIIb but not CaMKIIa regulated the movement and branching of filopodia and fine dendrites in rat hippocampal neurons (Fink et al., 2003) . In contrast, in Xenopus retinotectal neurons, CaMKII was reported to limit dendritic outgrowth and to stabilize dendritic arborization in vivo (Wu and Cline, 1998) .
In contrast to CaMKII, which is one of most abundant proteins expressed in the postsynaptic density (PSD) (Kennedy, 2000) , CaMKIV in the nucleus plays a critical role in mediating Ca 2+ -regulated transcription via a CREB/CBP pathway, which is necessary for the formation of long-term synaptic plasticity and long-term memory (Silva et al., 1998; Bito and Takemoto-Kimura, 2003) , as well as activity-dependent dendritic elongation (Redmond et al., 2002) . In turn, a cytosolic CaMKI activity has been shown to participate in the gating of an ERK/MAP-kinasedependent form of LTP (Schmitt et al., 2005) . Neurite outgrowth was also reported to be regulated by a presumably cytosolic CaMKK-CaMKI/IV pathway: indeed, a constitutively active CaMKIV was suggested to enhance dendritic growth via stabilization of b-catenin (Yu and Malenka, 2003) , while a CaMKK inhibitory drug, STO-609, or putative dominant-negative constructs specifically blocking either CaMKK or cytosolic CaMKI/CaMKIV (but not nuclear CaMKIV) activities prevented axonal extension and growth cone dynamics as well as neurite extension (Schmitt et al., 2004; Wayman et al., 2004) .
Taken together, multiple CaM kinase pathways that are segregated in distinct subcellular compartments may regulate several critical steps converging onto dendrite elongation and maturation. This prompted us to investigate the particular role of CL3/CaMKIg (Takemoto- Nishimura et al., 2003) , a membraneanchored form of CaMKI, which was highly expressed in the cortical plate neurons of the mouse embryo (this study). Intriguingly, we found a specific impairment in the number and total lengths of dendrites in CL3 knockdown and CL3 null neurons (Figure 4 and Figure S3 ), while axonal morphology was not significantly distinct from controls. Knockdown of CL3 prior to plating of neurons strengthened this suppressive effect on the dendrites while still sparing the axons ( Figure S4 ). Taken together, our data suggested a prominent role of CL3 during the early stages of dendritogenesis that presumably followed completion of the axon/dendrite specification.
While this paper was under review, an independent study reported that CL3/CaMKIg may regulate activitydependent dendritic growth at an even later stage of development in hippocampal neurons (Wayman et al., 2006 ; see also Figures S6 and S7 of this study). (A) Cortical neurons were transfected with a morphological tracer, mCherry, and cultured in the presence of various combinations of raft-depleting agents from 6 hr to 48 hr after plating. Disruption of cholesterol/sphingolipid synthesis strongly inhibited formation and outgrowth of the dendritic processes around the soma. Scale bar, 50 mm. (B) Ensemble average of experiments shown in (A). DMSO, n = 10; 10 mM mevastatin, n = 15; 10 mM fumonisin B 1 , n = 15; 10 mM fumonisin B 1 and 10 mM mevastatin, n = 15; 100 mM zaragozic acid, n = 15; 100 mM zaragozic acid and 10 mM mevastatin, n = 15. ***p < 0.001 (ANOVA with post hoc Tukey-Kramer test). (C) Raft depletion using zaragozic acid abolished the increase of dendritogenesis induced by CL3 overexpression. A significant CL3-mediated increase in dendritic growth was shown in the DMSO control, but this significant increase was abolished by raft depletion in the presence of zaragozic acid (two-way ANOVA, CL3 effect, F 1,65 = 8.65, p = 0.0045; drug effect, F 1,65 = 51.95, p < 0.0001; CL3 3 drug, F 1,65 = 8.38, p = 0.0052). ***p < 0.001 (post hoc Bonferroni test). DMSO, n = 15 (ÀCL3), n = 24 (+CL3), 100 mM zaragozic acid, n = 15 (ÀCL3), n = 15 (+CL3).
trafficking and function of palmitoylated signaling proteins (Huang and El-Husseini, 2005) . Dynamic regulation of palmitoylation was already shown for a large number of synaptic constituents such as AMPA-receptor subunits (Hayashi et al., 2005) , GABAR g-subunits (Keller et al., 2004) , and GRIP/ABP (DeSouza et al., 2002) , indicating a critical role for neuronal PAT in synaptic maturation and maintenance. However, a direct involvement of protein palmitoylation in early stages of neuronal morphogenesis has not been examined.
In this work, we demonstrated that the C-terminal end of CL3 was covalently modified in a sequential manner by prenylation and by palmitoylation. A dually lipidified CL3 was generated in a kinase-activity-dependent manner, in part via the PAT GODZ (Uemura et al., 2002) , resulting in an efficient enrichment into dendritic-raft-like lipid microdomains.
We then found that dually lipidified CL3 was likely to be partitioned and targeted to close proximity of dendritic lipid microdomains. Consistently, CL3 showed selfassociation ( Figure 2C and Figure S2A ), a property that is not unusual for palmitoylated or dually lipidified proteins (Zacharias et al., 2002) . However, we failed to detect any Ca 2+ /CaM-independent kinase activity of CL3, even under conditions where CL3 multimerization was present. This is distinct from the property of CaMKII, in which dodecamerization was shown to promote a Ca 2+ /CaM-independent kinase activity that outlasted the duration of the incoming Ca 2+ mobilization through an autophosphorylation mechanism. We thus speculate that oligomerization, if any, of prenyl-/palmitoyl-CL3 may have roles other than the generation of an autonomous kinase activity, such as sustaining a high degree of molecular proximity and concentration that favors signal amplification and increases the specificity and efficiency of coupling to downstream signaling events.
A BDNF-CL3-Rac Pathway May Underlie ExcitationMorphogenesis Coupling during Early Cortical Dendritogenesis Previously, neuronal activity has been shown to promote initiation of dendrite formation via small GTPases such as Rac and Cdc42 (Luo, 2002; Van Aelst and Cline, 2004) . To date, however, knowledge about how neuronal activity regulates these small GTPases is still limited. The strongest evidence in favor of activity-induced dendritic arborization so far involved several Ca 2+ -regulated transcriptional factor such as CREB, NeuroD, and CREST (Gaudilliere et al., 2004; Konur and Ghosh, 2005) , though the cellular mechanisms linking nuclear events and neuronal morphogenesis remained as yet largely undetermined. Here we found that a membrane-bound CaM kinase, CL3/ CaMKIg, may possibly act downstream of BDNF and Ca 2+ signals to promote dendritic cytoskeletal remodeling via the small GTPase Rac, especially during early stages of dendritic development. Furthermore, we provided several lines of evidence that collectively indicated that CL3-STEF-Rac signaling triggered at or in the vicinity of lipid rafts may play a critical role.
Could lipid rafts, also known as sphingolipid-and cholesterol-rich membrane microdomains, be distributed in an asymmetric fashion such that some of these may influence dendrite targeting of signaling proteins such as CL3? In support for such an idea, depletion of cellular cholesterol/sphingolipid content in cultured neurons revealed an important role for cholesterol (Fan et al., 2002) or sphingolipids (Schwarz and Futerman, 1998; Pelled et al., 2003) in dendritic growth and spine maintenance (Hering et al., 2003) . In addition, no responsiveness to glutamate application was reported in neonatal cortical neurons of a mutant mouse deficient in cholesterol biosynthesis, despite a normal amount of GluR and NMDAR subunit expression, indicating a possible defect in membrane insertion of dendritic glutamate receptors (Wassif et al., 2001) . A distinct kind of raft-mediated asymmetry may play a role in axonal fate specification (Da Silva et al., 2005) .
If raft formation was coupled with the creation of a polarized asymmetry of signaling molecule distribution, how could this possibly underlie a morphogenetic response, especially downstream of BDNF? Recruitment of activated TrkB to lipid rafts (Suzuki et al., 2004) could evidently contribute to efficient coupling to raft-targeted CL3 downstream of BDNF. In neurons, fractionation experiments during development have also previously revealed a privileged association of Rac with rafts, but not of RhoA or Cdc42 (Kumanogoh et al., 2001 ; see also Figure 6E ). We additionally found that a portion of STEF was clearly present in the raft fractions as well ( Figure 6E ). As the fragment encompassing the PHnTSS domain of STEF (PHnTSS) has been shown to act as a specific dominant-negative form for both STEF and Tiam1 (Matsuo et al., 2002) , it remains possible that there may also be an additional contribution of Tiam1, a known substrate for CaMK activity (Tolias et al., 2005) .
Taken together, dual lipidification of CL3 may be an efficient mechanism not only to target it into rafts and to limit its protein diffusion parallel to the lipid bilayer, but also to generate a membrane-delimited area of Rac activation within segregated dendritic lipid microdomains at the vicinity of Ca 2+ -mobilization events. Further studies are needed to substantiate such a hypothesis.
In conclusion, we here uncovered a novel role for CL3/ CaMKIg in the regulation of Rac-dependent dendritic cytoskeletal reorganization, and we found evidence for CL3 in mediating BDNF-stimulated dendritic growth. Through a dual and sequential lipidification mechanism, the unique C-terminal region of CL3 was covalently lipidmodified in a kinase-activity-dependent manner, leading to a privileged partition of membrane-anchored CL3 into dendritic-raft-like lipid microdomains. This membranesorting mechanism, unprecedented for a neuronal Ser/ Thr kinase, in turn may efficiently localize Rac activity and thereby regulate dendritogenesis. Thus, CL3 turned out to represent a key element in the Ca 2+ -dependent and lipid-raft-delineated switch that turned on activity-regulated dendrite formation in developing cortical neurons.
EXPERIMENTAL PROCEDURES
Cloning and Plasmid Constructions A detailed description of all plasmids can be found in the Supplemental Data.
Immunocytochemistry Cells were fixed in 4% paraformaldehyde/4% sucrose/phosphatebuffered saline (PBS) (À) at room temperature for 20 min, and immunostaining was carried out as described . Additional methods can be found in the Supplemental Data.
Western Blot Analysis
For western blot analysis, primary antibodies were as follows: rat anti-GFP (Nacalai Tesque, Japan), rat anti-HA (Roche Diagnostics), mouse anti-Flotillin-1, mouse anti-Caveolin-2, and anti-Rac1 (BD Transduction Laboratories). A rabbit anti-STEF antibody was as described (Matsuo et al., 2002) . Chemiluminescence detection was performed using HRP-conjugated anti-rat and anti-mouse IgG and ECL-Plus reagent (Amersham Biosciences).
Metabolic Labeling and Coimmunoprecipitation
For metabolic labeling, COS-7 cells plated onto 6-well plates were transfected with wild-type and mutant GFP-CL3 vectors using Fugene6 reagent (Roche Diagnostics). For mevalonate labeling, a pMev vector (ATCC), which encoded a transporter that augmented mevalonic acid uptake, was cotransfected with GFP-CL3 for 24 hr. Cells were pretreated with 40 mM Compactin (Wako, Japan) for 2 hr, then incubated for 20 hr in growth medium supplemented with 40 mM Compactin and 0.1 mCi/ml of [ 3 H]-mevalonolactone (PerkinElmer or ARC). Palmitate labeling was initiated 48 hr after transfection by pretreating cells with serum-free medium (DMEM with 1% fattyacid-free bovine serum albumin [Sigma]) for 1 hr, and then incubating for an additional 3 hr in the serum-free medium supplemented with 0.4 mCi/ml of [ 3 H]-palmitic acid (PerkinElmer). After metabolic labeling, cells were washed twice in ice-cold phosphate-buffered saline (PBS) (À) and lysed in lysis buffer containing 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 2 mM MgCl 2 , 10% glycerol, 1% Triton X-100, and a Complete protease inhibitor cocktail (Roche Diagnostics). Lysates were immunoprecipitated using a rabbit anti-GFP polyclonal antibody (Molecular Probes) and Protein-A-Sepharose (Amersham Biosciences). Immunoprecipitates were washed three times in lysis buffer and boiled in 43 Laemmli buffer containing 5 mM DTT for 3 min and were subjected to SDS-PAGE. Incorporated mevalonolactone and palmitic acid were digitally detected using a BAS-5000 bioimage analyzer and quantified using Multi Gauge software (Fujifilm, Japan). In coimmunoprecipitation assays, cortical neurons were transfected with GFP-CL3 and HA-CL3 vectors by electroporation using Nucleofector (Amaxa Biosystems) and plated onto poly-D-Lysine-coated 6 cm dishes at the density of 4 3 10 5 /cm 2 and then harvested at 2 DIV. Immunoprecipitation was performed as described above.
Lentivirus Production, Infection, and Lipid Raft Fractionation A 536 bp synapsin I promoter was isolated by PCR from rat genomic DNA and inserted into CS-CA-MCS (Miyoshi et al., 1998) to replace the original chicken actin promoter. EGFP-CL3 fragment was further inserted and cotransfected with pCAG-HIVgp and pCMV-VSV-G-RSV-Rev into HEK293T cells using Fugene6 reagent to generate a self-inactivating lentivirus vector. All original lentivirus vectors were provided by Dr. Hiroyuki Miyoshi (RIKEN-BRC, Japan). Concentrated virus solutions were obtained by ultracentrifugation at 80,000 3 g, and virus titer was determined using HeLa cells. Cortical neurons
(1 DIV) were infected with lentivirus for 5 hr at a nominal MOI of about 0.2, and after washout, maintained in Neurobasal containing 0.5 mM Glutamax, 1 3 B27, and 25 mg/ml insulin. Under these conditions, GFP-positive glial cells (as determined by GFAP expression) were less than 6%. Though the nominal MOI was about 0.2, this is very likely to be an underestimate, as it was calculated based on the induction of trace EGFP fluorescence in heterologous cells. Lipid raft preparations were performed 2 days after infection (3 DIV). Lentivirus-infected cortical neurons in 10 cm dishes (3.5 3 10 5 cells/ cm 2 ) were harvested at 3 DIV for preparation of detergent-insoluble membrane fractions according to Suzuki et al. (2004) with minor modifications. Thirteen fractions (1 ml each) were collected and 15 ml of each fraction were subjected to SDS-PAGE followed by western blot analysis. To obtain a concentrate of the raft fractions in Figure 5E , raft fractions (fractions 4 and 5) were pooled, and a portion of it (1.4 ml) was ultracentrifuged at 20,000 3 g for 1 hr at 4 C. The pellet was resuspended in 140 ml of Buffer A (50 mM Tris-HCl [pH 7.5], 50 mM NaCl), and 15 ml of the final sample was subjected to SDS-PAGE and western blot analysis.
Cell Culture Preparation and Visualization of Raft-Targeted Proteins COS-7 cells were maintained in Dulbecco's modified Eagle medium (DMEM) containing 10% heat-inactivated fetal calf serum (FCS). Dissociated cortical cultures from embryonic day 19 Sprague-Dawley rats were prepared as described previously for rat hippocampal cultures (Bito et al., 1996) with minor modifications. Cortical neurons were plated onto 12 mm poly-L-Lysine-coated coverslips at the density of 5 3 10 5 cells per coverslip in a 24-well plate.
Gene targeting of CL3/CaMKIg was carried out in a C57BL/6-derived ES cell line RENKA (Mishina and Sakimura, 2007) by insertional mutagenesis. The exons 2 and 3 of mouse the Camk1g gene, which contained the kinase ATP-binding site, were deleted and replaced by a targeting construst such that the first methionine of CL3 was fused in-frame to an hCrePR-IRES-EGFP cassette that was juxtaposed to an inverted neomycin resistance gene flanked by FRT sites. A detailed analysis of the CL3/CaMKIg null mouse mutant will be described elsewhere (S.T.-K., M.O., T. Takeuchi, K. Sakimura, M.M., H.O., and H.B, unpublished data). Cortical mouse cultures were prepared from embryonic day 17 C57BL/6J wild-type or CL3 null mice.
For visualization of in situ raft-targeted GFP-fusion proteins, rat cortical or mouse hippocampal neurons were washed with KRH buffer (Suzuki et al., 2004) containing 2 mM Ca 2+ on ice, permeabilized with 0.1% Triton X-100/KRH(+) for 2 min on ice, washed gently, and then fixed. Raft depletion in cortical neurons was carried out by including one of the following drugs (10 mM mevastatin, 10 mM fumonisin B 1 , 10 mM fumonisin B 1 and 10 mM mevastatin, 100 mM zaragozic acid, 100 mM zaragozic acid, and 10 mM mevastatin) in the culture medium from 6 hr after plating onward for an additional 42 hr. mRFP1 was nucleofected for accurate visualization of the contours of individual neurons. In one instance, rat hippocampal neurons obtained from P0-1 Sprague-Dawley rats (Bito et al., 1996) were used to quantify FRET between CL3 molecules ( Figure S2A ).
Morphometric Analysis of the CL3-Associated Phenotype in Cultured Neurons
Dissociated cortical cultures from embryonic day 19 Sprague-Dawley rats were prepared as described previously for rat or mouse hippocampal cultures (Bito et al., 1996; Furuyashiki et al. 2002) with minor modifications. Cortical neurons were transfected immediately after dissociation by electroporation using Nucleofector and plated onto 12 mm poly-L-Lysine-coated coverslips at the density of 5 3 10 5 cells per coverslip (rats) or 7.5 3 10 5 cells per coverslip (mice) in 24-well plates, and then fixed at 2 DIV. Presumably because of a relatively low amount of plasmid transfer across neuronal membranes during electroporation procedure, use of a strong CAG promoter-driven expression cassette was needed to reliably express foreign genes.
Further, to unequivocally ascertain the phenotypes of neurons expressing various shRNA vectors and rescue constructs, we carried out all quantitative analyses based upon immunostaining of the morphometric markers, either GFP or mRFP1 (a kind gift from Dr. Roger Y. Tsien, HHMI, UCSD). This allowed us to obtain clearer images of neuronal contours, thus facilitating morphometric analyses. The transfection efficiency was relatively high (about 50% in our hands using this protocol) when examined within a day after electroporation. Thus, we were able to improve the accuracy of visualization in all morphometric experiments by simply mixing the transfected cells with nontransfected cells prepared in parallel, at a ratio of 1:20 (rats) or 1:10 (mice), before plating. Dendritic and axonal arborizations of most transfected neurons could then be traced in total isolation while they still formed a dense network with neighboring untransfected neurons. Neurons expressing pSUPER-type vectors revealed negligible amounts of either cell death (0%-0.5%) as measured by TUNEL staining (Roche Diagnostics) or dsRNA-induced interferon-like response monitored using a muMx2 promoter-luc vector (a kind gift from Dr. Atsushi Asano, Hokkaido University) (Alvarez et al., 2006) . In the Rac1-rescue experiments, even an intermediate-level expression of a constitutively active Rac mutant, GFP-V12Rac1, using a CAG promoter usually resulted in an aberrant neuronal morphology, such as exuberant lamellipodia formation at the cell soma and premature detachment from the glass coverslip. To circumvent this problem, GFP-V12Rac1 was introduced using a CMV promoter-based plasmid vector, as the observed expression level was lower than that obtained using a CAG promoter vector. A few neurons still showed an aberrant somata size and shape and thus were excluded from analyses.
Images of neuronal morphologies were captured based on immunoreactivities against GFP or mRFP1, using the Olympus BX51 microscopy system with the 203 objective or 403 objective in the cases of CL3-overexpression experiments to visualize fine protrusions for cumulative probability analysis. Dendrites and axons were identified by standard morphological criteria. As the majority of neurons, in our cortical culture preparation, possessed only one clearly classifiable axon and one or more dendrites, neurons with nonpyramidal morphological features (such as multiple axons or no classifiable processes) were excluded from analyses. The total length and the dendritic branch tip number were determined manually using NeuronJ 1.1.0 (Meijering et al., 2004) , plug-in software for ImageJ (NIH). Representative images were acquired using the LSM 510META confocal microscope with the 403 objective. All analyses were performed by an observer blinded to the identity of the transfected constructs.
In experiments described in Figure S4 , electroporated neurons were initially cultured as a suspension in a growth medium, without plating, in plastic centrifuge tubes at the density of 2 3 10 6 cells/ml, while neurons were allowed to form aggregation. Forty-eight hours later, aggregated neurons were then dissociated mechanically by gentle pipetting and plated onto 12 mm poly-L-Lysine-coated coverslips at the density of 1 3 10 6 cells per coverslip. Fixation and analysis were carried out 24 hr later. Mouse hippocampal neurons were transfected using Lipofectamine 2000 (Invitrogen) at 7 DIV and analyzed at 9 DIV. Morphometric analyses of hippocampal neurons were performed as essentially described above for cortical neurons. Only primary dendrites were traced using ImageJ/NeuronJ software.
In Situ Hybridization
In situ hybridization using DIG technology (Roche Diagnostics) was performed essentially as described (Ohmae et al., 2006) . For the generation of antisense and sense cRNA probes, a 374 bp fragment corresponding to the nucleotide position 964-1337 of CL3 was subcloned into pBluescriptII KS+ vector (Stratagene).
BDNF Application and Calcium Imaging in Cortical Neurons
BDNF (generously provided by Dainippon Sumitomo Pharma, Osaka, Japan, by courtesy of Dr. Chikao Nakayama) and/or KN-93 (Calbiochem) were added to cells at 6 hr after plating at the final concentration of 50 ng/ml and 10 mM, respectively. Bath application was performed by dissolving the reagents in one-half volume of the conditioned culture medium and by mixing this gently with the remaining half of the original medium in the dish. No medium change was done thereafter till fixation.
Fluorescent calcium imaging was performed essentially as described previously (Furuyashiki et al., 2002) . A detailed description of further experimental conditions can be found in the Supplemental Data.
Rac1 Pull-Down Assays, Measurement of Fluorescence Resonance Energy Transfer, and Quantification of Golgi Deformation A detailed description of experimental procedures can be found in the Supplemental Data.
Statistical Analysis
Statistical analyses were performed using Prism 4.0 (GraphPad Software) and JMP5.1.2 (SAS Institute). Student's t test was used for comparisons of two groups. One-or two-way analysis of variance (ANOVA) with post hoc Tukey-Kramer or Bonferroni test was used for factorial analysis between more than three groups. The Kolmogorov-Smirnov test was applied to verify whether the bidirectional effect of CL3 manipulation occurred throughout all dendrites or was restricted to a subpopulation. All data are shown as mean ± standard error of means (SEM), unless otherwise mentioned.
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.neuron.org/cgi/content/full/54/5/755/DC1/.
